Guidelines to Manage Community-Acquired Pneumonia

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Few guidelines have greater acceptance than that for management of community-acquired pneumonia (CAP). Despite this, areas remain controversial, and new challenges continue to emerge. Current guidelines differ from those of northern European countries predominantly in need for macrolide combination with β-lactams for hospitalized, non–intensive care unit patients. A preponderance of evidence favors combination therapy. Challenges for current and future CAP guidelines include new antibiotic classes, emergence of viruses as major causes for CAP, new diagnostic modalities, alternative risk stratification for pathogens resistant to usual CAP antibiotics, and evidence-based management of severe CAP, including immunomodulatory therapy such as corticosteroids.

Original languageEnglish (US)
Pages (from-to)723-731
Number of pages9
JournalClinics in Chest Medicine
Volume39
Issue number4
DOIs
StatePublished - Dec 2018

Keywords

  • Community-acquired pneumonia
  • Corticosteroids
  • Macrolide
  • Pneumonia
  • Procalcitonin
  • Viral pneumonia

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Guidelines to Manage Community-Acquired Pneumonia'. Together they form a unique fingerprint.

  • Cite this